Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Peter MacCallum Cancer Centre,Trans Tasman Radiation Oncology Group (TROG)
Scientific Title
A Randomised Phase II Trial Comparing the Efficacy of Single-fraction or Multi-fraction SABR (Stereotactic Ablative Body Radiotherapy) With AteZolizumab in Patients With Advanced Triple nEgative Breast Cancer